Nitric oxide in experimental joint inflammation: Benefit or detriment?

Cells Tissues Organs

Volumn 174, Issue 1-2, 2003, Pages 26-33

  Wahl, Sharon M ^a,c   McCartney Francis, N ^a   Chan, J ^a   Dionne, R ^a   Ta, L ^a   Orenstein, J M ^b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Arthritis; Inflammation; Nitric oxide; Temporomandibular joint disorder; Tumor necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; ARGININE; CALCIUM ION; CALMODULIN; FC RECEPTOR; GUANIDINE DERIVATIVE; GUANIDINONITROGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 1; ISOENZYME; LYSINE DERIVATIVE; N IMINOETHYLLYSINE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PEPTIDOGLYCAN; POLYSACCHARIDE; PROTEIN P75; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTAGONIST; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTHROPATHY; BACTERIAL ARTHRITIS; BACTERIAL CELL WALL; BLOOD LEVEL; CALCIUM TRANSPORT; CATALYSIS; CELL ACTIVATION; CELLULAR IMMUNITY; COMPLEX FORMATION; CONFERENCE PAPER; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFECT; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TRANSFER; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOPATHOLOGY; INFLAMMATION; LIVER; MICROBIAL ACTIVITY; MONONUCLEAR PHAGOCYTE; NERVE CELL; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; STREPTOCOCCUS; SYNOVIUM; T LYMPHOCYTE; TARGET ORGAN; TISSUE INJURY; UPREGULATION;

ANIMALS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TEMPOROMANDIBULAR JOINT DISORDERS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0037977031     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070572     Document Type: Conference Paper

References (36)

1. Abramson, S., A. Amin, R. Clancy, M. Attur (2001) The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 15: 831-845.
2. Allen, J., H. Wong, G. Costa, M. Bienkowski, S. Wahl (1993) Suppression of monocyte function and differential regulation of IL-1 and IL-1ra by IL-4 contribute to resolution of experimental arthritis. J Immunol 151: 4344-4351.
3. Bogdan, C. (2001) Nitric oxide and the immune response. Nat Immunol 2: 907-916.
4. Carlsson, G., L. LeResche (1995) Epidemiology of temporomandibular disorders; in Sessle, B., P. Bryant, R. Dionne (eds): Temporomandibular Disorders and Related Pain Conditions. Seattle, IASP Press, pp 211-226.
5. Chan, J., G. Villarreal, W. Jin, T. Stepan, H. Burstein, S. Wahl (2002) Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 6: 727-736.
6. Fiorucci, S. (2001) NO-releasing NSAIDS are caspase inhibitors. Trends Immunol 22: 232-235.
7. Fiorucci, S., L. Santucci, E. Antonelli, E. Distrutti, G. del Sero, O. Morelli, L. Romani, B. Federici, P. del Soldato, A. Morelli (2000) NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology 118: 404-421.
8. Fu, K., X. Ma, Z. Zhang, W. Chen (1995) Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 53: 424-426.
9. Gilkeson, G., J. Mudgett, M. Seldin, P. Ruiz, A. Alexander, M. Misukonis, D. Pisetsky, J. Weinberg (1997) Clinical and serologic manifestations of autoimmune disease in MRL-1pr/ 1pr mice lacking nitric oxide synthase type 2. J Exp Med 186: 365-373.
10. Graninger, W., J. Smolen (2002) Treatment of rheumatoid arthritis by TNF-blocking agents. Int Arch Allergy Immunol 127:10-14.
11. Grisham, M.B., K.P. Pavlick, F.S. Laroux, J. Hoffman, S. Bharwani, R.E. Wolf (2002) Nitric oxide and chronic gut inflammation: Controversies in inflammatory bowel disease. J Invest Med 50: 272-283.
12. Hines, K., M. Christ, S. Wahl (1993) Cytokine regulation of the immune response: An in vivo model. Immunomethods 3: 13-22.
13. Holmlund, A., G. Gynther, F. Reinholt (1992) Rheumatoid arthritis and disk derangement of the temporomandibular joint. A comparative arthroscopic study. Oral Surg Oral Med Oral Pathol 73: 273-277.
14. Homma, H., T. Takahashi, H. Seki, M. Ohtani, T. Kondoh, M. Fukuda (2001) Immunohistochemical localization of inducible nitric oxide synthase in synovial tissue of human temporomandibular joints with internal derangement. Arch Oral Biol 46: 93-97.
15. Kacena, M., G. Merrel, S. Konda, K. Wilson, Y. Xi, M. Horowitz (2001) Inflammation and bony changes at the temporomandibular joint. Cells Tissues Organs 169: 257-264.
16. Kolb, H., V. Kolb-Bachofen (1998) Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator? Immunol Today 19: 556-561.
17. Kubes, P. (2000) Inducible nitric oxide synthase: A little bit of good in all of us. Gut 47: 6-9.
18. MacMicking, J., Q. Xie, C. Nathan (1997) Nitric oxide and macrophage function. Ann Rev Immunol 15: 323-250.
19. McCartney-Francis, N., J. Allen, D. Mizel, J. Albina, Q. Xie, C. Nathan, S. Wahl (1993) Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 178: 749-754.
20. McCartney-Francis, N., X. Song, D. Mizel, C. Wahl, S. Wahl (1999) Hemoglobin protects from streptococcal cell wall-induced arthritis. Arthritis Rheum 42: 1119-1127.
21. McCartney-Francis, N., X. Song, D. Mizel, S. Wahl (2001) Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol 166: 2734-2740.
22. McInnes, I., B. Leung, X. Wei, C. Gemmell, F. Liew (1998) Septic arthritis following Staphylococcus aureusinfection in mice lacking inducible nitric oxide synthase. J Immunol 160: 308-315.
23. Moore, W., R. Webber, G. Jerome, F. Tjoeng, T. Misko, M. Currie (1994) L-N6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886-3888.
24. Nathan, C. (1997) Perspective series: Nitric oxide and nitric oxide synthases. J Clin Invest 100: 2417-2423.
25. Salerno, L., V. Sorrenti, C. Di Giacomo, G. Romeo, M. Siracusa (2002) Progress in the development of selective nitric oxide synthase (NOS) inhibitors. Curr Pharm Des 8: 177-200.
26. Salvesen, G., V. Dixit (1997) Caspases: Intracellular signaling by proteolysis. Cell 91: 443-446.
27. Shafer, D., L. Assael, L. White, E. Rossomando (1994) Tumor necrosis factor-alpha as a biochemical marker of pain and outcome in temporomandibular joints with internal derangements. J Oral Maxillofac Surg 52: 786-791.
28. Singh, V., S. Mehrotra, P. Narayan, C. Pandey, S. Agarwal (2000) Modulation of autoimmune diseases by nitric oxide. Immunol Res 22: 1-19.
29. Song, X., G. MiLi, W. Jin, D. Klinman, S. Wahl (1998) Plasmid DNA encoding transforming growth factor-β1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model. J Clin Invest 101: 2615-2621.
30. Song, X., L. Zeng, W. Jin, C. Pilo, M. Frank, S. Wahl (2000) Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Arthritis Rheum 43: 2064-2072.
31. Song, X., L. Zeng, W. Jin, J. Thompson, D. Mizel, K. Lei, R. Billinghurst, A. Poole, S. Wahl (1999) Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J Exp Med 190: 535-542.
32. Suenaga, S., K. Abeyama, A. Hamasaki, T. Mimura, T. Noikura (2001) Temporomandibular disorders: Relationship between joint pain and effusion and nitric oxide concentration in the joint fluid. Dentomaxillofac Radiol 30: 214-218.
33. Ta, L., J. Phero, S. Pillemer, H. Hale-Donze, N. McCartney-Francis, A. Kingman, M. Max, S. Gordon, S. Wahl, R. Dionne (2002) Clinical evaluation of patients with TMJ implants. J Oral Maxillofac Surg 60: 1389-1399.
34. Takahashi, T., T. Kondoh, K. Kamei, H. Seki, M. Fukuda, H. Nagai, H. Takano, Y. Yamazaki (1996) Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 82: 505-509.
35. Takahashi, T., T. Kondoh, M. Ohtani, H. Homma, M. Fukuda (1999) Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 129-136.
36. Trumpy, I., B. Roald, T. Lyberg (1996) Morphologic and immunohistochemical observation of explanted Proplast-Teflon temporomandibular joint interpositional implants. J Oral Maxillofac Surg 54: 63-68.